# Panobinostat Biological Correlates Study

> **NCT01658241** · PHASE2 · COMPLETED · sponsor: **Peter MacCallum Cancer Centre, Australia** · enrollment: 30 (actual)

## Conditions studied

- Nodal Lymphoma
- Lymphoma With Cutaneous Involvement
- Lymphoma in Leukemic Phase
- Marrow Involvement With Lymphoma
- Multiple Myeloma

## Interventions

- **DRUG:** panobinostat

## Key facts

- **NCT ID:** NCT01658241
- **Lead sponsor:** Peter MacCallum Cancer Centre, Australia
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-07-16
- **Primary completion:** 2015-03-18
- **Final completion:** 2015-03-18
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2022-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01658241

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01658241, "Panobinostat Biological Correlates Study". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01658241. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*